into a functional cell, such as a nerve, muscle, fat, bone, or blood cell before it is of any use in therapy [11] . Completely new technologies, based on innovative and complex molecular and genetic experimentation, must be developed before the virtual miracle expected in stem cell treatment can be realized. To understand the complexity of what we expect from a stem cell, a colony of such cells, infused intravenously or injected directly into brain or spinal cord, must then find their way to the site where these cells are needed. They must be able to defend themselves or hide from attacks of the patient's immune system. If infused intravenously, they must not become stuck in the liver or lung on their way to the injured target site. There, they must then be transformed start to reproduce and be able to function.
Up to dozens of commercial clinics worldwide are advertising some stem cell treatments without any scientifically acceptable substantiated evidence that the treatments are safe and effective. Such clinics are usually located in countries that have lax laws dealing with such practices, or lax enforcement of existing laws. These countries may not provide for supervision or licensing of such activities allowing the laws to be evaded, corrupted, or skirted around by what is now a very lucrative and growing industry [1, 12, 13] . Documented success and failure data from some such clinics cannot be found in the scientific literature. However, testimonials abound in the media and material offered by such clinics [1, 14] . Testimonials can be elicited from patients, but these alone are not sufficient evidence of effectiveness or safety. The evidence that "some patients seem to have benefited from the treatment" is not sufficient. The evidence must be subject to the stricter rules of scientific enquiry and must be verified, and this can only be done by long-term peer reviewed and unbiased follow-ups. Many of the diseases treated by this group of very profitable providers have slowly progressive natural histories, remissions, and exacerbations. To determine efficacy and safety requires studies of large numbers of patients for long periods of time [15] . Patients who seek "last chance" experimental treatments for terminal or otherwise incurable conditions, after having apparently exhausted other avenues, are especially vulnerable to medical charlatans who openly prey on the vulnerable with impunity, and these patients may have little or no legal recourse. Reputable international research centers that carry out legitimate trials of promising new technologies are often open for patients to volunteer for clinical trials of experimental treatments. There are several places to obtain more information regarding legitimate clinical trials [16, 17] .
In Asia, there are commercial stem cell treatment centers in many countries including Thailand, Malaysia, India, The Philippines, China, and Hong Kong. Efforts have been made by several medical authorities and governments to regulate unethical, unproven, and sometimes criminal conduct by so-called "Stem Cell Centers" [12] . However, even in the tightly regulated United States of America, there are unscrupulous doctors and others who attract desperate patients and refer them to clinics abroad for profit. The U.S. FDA has warned consumers about stem cell claims [18] . Asian Biomedicine restricts itself to publish only work that is substantiated scientifically, approved by an ethics committee, peer reviewed, and acceptable on moral and ethical stands [19] . We and other legitimate organizations strongly discourage stem cell therapy tourism at this still early time [14, 15, 20] . Patients who do contemplate undergoing stem cell treatment abroad, should first carefully educate themselves concerning current knowledge and consult their personal physicians and medical institutions back home. Medical tourism now and in the future may include "proven stem cell therapies". Such treatments, e.g. hematopoietic stem cell treatment for certain hematological diseases such as leukemia, may not be available or may be prohibitively expensive for patients in their own countries. In the future, other proven treatments, perhaps involving the use of embryonic stem cells, may be banned in certain countries for political or religious reasons. Patients should remain free to travel to clinics offering proven stem cell-based therapies. However, they must be able to distinguish between acceptable medical travel for proven therapies and problematic stem cell tourism. In this issue of Asian Biomedicine, Malaysian religious perspectives regarding the ethics of embryonic stem cell research are reviewed by Sivaraman and Noor [21] . Stem cells offer exciting promise for future therapies, but significant technical hurdles remain that will only be overcome through extensive and intensive research. Two articles in this issue of Asian Biomedicine address stem cell technology. The article by Ai et al. from Iran [22] reports original research and the other by Hua et al. from China [23] reviews therapeutic cloning in the light of induced pluripotent stem cell technology.
